Mid-day Update

PODCAST: Drugs, magazines, and bonds

David Brancaccio Jun 5, 2013
HTML EMBED:
COPY
Mid-day Update

PODCAST: Drugs, magazines, and bonds

David Brancaccio Jun 5, 2013
HTML EMBED:
COPY

The FDA is expected to take another look at controversial diabetes drug Avandia after researchers at Duke have concluded the drug doesn’t increase the risk of cardiovascular death as previously reported. But is it too little too late?

Shelter magazines are on the rebound as the housing industry bounces back. What other lateral signs are there out there?

Stocks are risky, but bonds are safe, or so goes the stereotype. Buy a solid bond — the logic goes — and you get your money back at maturity with interest. Then there are bond mutual funds, which are built on bonds, but are a very different animal than straight up bonds. As interest rates have risen over the past month, dividends for some of the nation’s largest bond funds have been all but wiped out.

There’s a lot happening in the world.  Through it all, Marketplace is here for you. 

You rely on Marketplace to break down the world’s events and tell you how it affects you in a fact-based, approachable way. We rely on your financial support to keep making that possible. 

Your donation today powers the independent journalism that you rely on. For just $5/month, you can help sustain Marketplace so we can keep reporting on the things that matter to you.